Botulinum toxin type A injections: Adverse events reported to the US Food and Drug Administration in therapeutic and cosmetic casesTimothy R. Coté, M. Miles Braun, Aparna Mohan et al.|Journal of the American Academy of Dermatology|2005Cited by 361
Challenges and opportunities in designing clinical trials for neuromyelitis opticaBrian G. Weinshenker, Michael R. Yeaman, Gerard Barron et al.|Neurology|2015Cited by 46